Drug-Drug Interaction Study With Rifampin

Clinical trial NCT01002079 · COMPLETED

Trial details

NCT number: NCT01002079
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2010-08-01
Primary completion: 2010-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.